PBP1510

anti-PAUF monoclonal antibody · Prestige Biopharma Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PBP1510, covering 2025-06-04 to 2025-06-04. Get the full timeline:

Most recent: Clinical Trial Update: First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic Cancer [Phase 1, Phase 2]

See pricing